Advances in Study on Novel Oral Biological Agents in Treatment of Inflammatory Bowel Disease / 胃肠病学
Chinese Journal of Gastroenterology
;
(12): 498-501, 2017.
Article
in Chinese
| WPRIM
| ID: wpr-610680
ABSTRACT
As a new therapy in past twenty years,biological agents have been approved for the treatment of inflammatory bowel disease (IBD). However,biological agents currently used for IBD treatment require intravenous or subcutaneous injections,and some require infusion under close observation. Therefore,it is of positive clinical significance to find a safe and effective oral biological agent. This article reviewed recent advances in study on novel oral biological agents in the treatment of IBD.
Full text:
Available
Index:
WPRIM (Western Pacific)
Language:
Chinese
Journal:
Chinese Journal of Gastroenterology
Year:
2017
Type:
Article
Similar
MEDLINE
...
LILACS
LIS